SENORES PHARMACEUTICALS
Back to Balance Sheet
|
SENORES PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹215 Cr | ₹155 Cr | ₹128 Cr | ₹34 Cr | ₹12 Cr |
What is the latest Total Non-Current Liabilities ratio of SENORES PHARMACEUTICALS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹215 Cr |
| Mar2025 | ₹155 Cr |
| Mar2024 | ₹128 Cr |
| Mar2023 | ₹34 Cr |
| Mar2022 | ₹12 Cr |
How is Total Non-Current Liabilities of SENORES PHARMACEUTICALS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹215 Cr | 38.66 | |
| Mar2025 | ₹155 Cr | 21.55 | |
| Mar2024 | ₹128 Cr | 279.35 | |
| Mar2023 | ₹34 Cr | 175.40 | |
| Mar2022 | ₹12 Cr | - | |
Compare Total Non-Current Liabilities of peers of SENORES PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SENORES PHARMACEUTICALS | ₹6,040.5 Cr | -0.4% | -9.9% | 69.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,283.0 Cr | -0.1% | -6.5% | 3.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹251,611.0 Cr | -0.2% | -5.5% | 35.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,182.0 Cr | 0.4% | -8.2% | 25.2% | Stock Analytics | |
| CIPLA | ₹109,063.0 Cr | 1.7% | -2% | -15.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,926.0 Cr | 4.9% | 7.7% | -2.5% | Stock Analytics | |
SENORES PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SENORES PHARMACEUTICALS | -0.4% |
-9.9% |
69.3% |
| SENSEX | -0.3% |
-1.6% |
-12.3% |
You may also like the below Video Courses